Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges-Reference-Cited by-同舟云学术

Autologous stem cell transplantation in favorable-risk acute myeloid leukemia: single-center experience and current challenges

Published:2022-05-13 Issue:4 Volume:116 Page:586-593
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Capria Saveria^ORCID,Trisolini Silvia Maria,Diverio Daniela,Minotti Clara,Breccia Massimo,Cartoni Claudio,Carmini Daniela,Gozzer Maria,La Rocca Ursula,Shafii Bafti Mahnaz,Martelli Maurizio

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-022-03370-4.pdf

Reference33 articles.

1. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

2. Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606. https://doi.org/10.1016/S0140-6736(18)31041-9.

3. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Ebert BL, et al. Diagnosis and management of AML in adults: 2017 ELNrecommendations from an international expert panel. Blood. 2017;129:424–48.

4. Burnett AK, Goldstone AH, Stevens RMF, Hann IM, Rees JKH, Gray RG, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial. Lancet. 1998;351(9104):700–8.

5. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med. 1995;332(4):217–23.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT;Bone Marrow Transplantation;2024-08-02

2. Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation;International Journal of Molecular Sciences;2024-07-27

3. Tunable Universal OR-gated CAR T cells for AML;2024-04-14

4. The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment;Blood Reviews;2023-11

5. Therapy-related core binding factor acute myeloid leukemia;International Journal of Hematologic Oncology;2023-03